Global Polio Vaccines Market Growth 2023-2029

February 2023 | 92 pages | ID: G65900F61571EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2023.

LPI (LP Information)' newest research report, the “Polio Vaccines Industry Forecast” looks at past sales and reviews total world Polio Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Polio Vaccines sales for 2023 through 2029. With Polio Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polio Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Polio Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polio Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Polio Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polio Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polio Vaccines.

The global Polio Vaccines market size is projected to grow from US$ 694.4 million in 2022 to US$ 819 million in 2029; it is expected to grow at a CAGR of 819 from 2023 to 2029.

Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 98% market shares.

This report presents a comprehensive overview, market shares, and growth opportunities of Polio Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• IPV
• OPV

Segmentation by application

• Age (0-1)
• Age Above 1

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• CSL
• GlaxoSmithKline
• Johnson & Johnson
• MedImmune
• Merck
• Pfizer
• Sanofi Pasteur
• Serum Institute

Key Questions Addressed in this Report

What is the 10-year outlook for the global Polio Vaccines market?

What factors are driving Polio Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Polio Vaccines market opportunities vary by end market size?

How does Polio Vaccines break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Polio Vaccines Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Polio Vaccines by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Polio Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Polio Vaccines Segment by Type
  2.2.1 IPV
  2.2.2 OPV
2.3 Polio Vaccines Sales by Type
  2.3.1 Global Polio Vaccines Sales Market Share by Type (2018-2023)
  2.3.2 Global Polio Vaccines Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Polio Vaccines Sale Price by Type (2018-2023)
2.4 Polio Vaccines Segment by Application
  2.4.1 Age (0-1)
  2.4.2 Age Above
2.5 Polio Vaccines Sales by Application
  2.5.1 Global Polio Vaccines Sale Market Share by Application (2018-2023)
  2.5.2 Global Polio Vaccines Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Polio Vaccines Sale Price by Application (2018-2023)

3 GLOBAL POLIO VACCINES BY COMPANY

3.1 Global Polio Vaccines Breakdown Data by Company
  3.1.1 Global Polio Vaccines Annual Sales by Company (2018-2023)
  3.1.2 Global Polio Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Polio Vaccines Annual Revenue by Company (2018-2023)
  3.2.1 Global Polio Vaccines Revenue by Company (2018-2023)
  3.2.2 Global Polio Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Polio Vaccines Sale Price by Company
3.4 Key Manufacturers Polio Vaccines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Polio Vaccines Product Location Distribution
  3.4.2 Players Polio Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR POLIO VACCINES BY GEOGRAPHIC REGION

4.1 World Historic Polio Vaccines Market Size by Geographic Region (2018-2023)
  4.1.1 Global Polio Vaccines Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Polio Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Polio Vaccines Market Size by Country/Region (2018-2023)
  4.2.1 Global Polio Vaccines Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Polio Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Polio Vaccines Sales Growth
4.4 APAC Polio Vaccines Sales Growth
4.5 Europe Polio Vaccines Sales Growth
4.6 Middle East & Africa Polio Vaccines Sales Growth

5 AMERICAS

5.1 Americas Polio Vaccines Sales by Country
  5.1.1 Americas Polio Vaccines Sales by Country (2018-2023)
  5.1.2 Americas Polio Vaccines Revenue by Country (2018-2023)
5.2 Americas Polio Vaccines Sales by Type
5.3 Americas Polio Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Polio Vaccines Sales by Region
  6.1.1 APAC Polio Vaccines Sales by Region (2018-2023)
  6.1.2 APAC Polio Vaccines Revenue by Region (2018-2023)
6.2 APAC Polio Vaccines Sales by Type
6.3 APAC Polio Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Polio Vaccines by Country
  7.1.1 Europe Polio Vaccines Sales by Country (2018-2023)
  7.1.2 Europe Polio Vaccines Revenue by Country (2018-2023)
7.2 Europe Polio Vaccines Sales by Type
7.3 Europe Polio Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Polio Vaccines by Country
  8.1.1 Middle East & Africa Polio Vaccines Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Polio Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Polio Vaccines Sales by Type
8.3 Middle East & Africa Polio Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polio Vaccines
10.3 Manufacturing Process Analysis of Polio Vaccines
10.4 Industry Chain Structure of Polio Vaccines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Polio Vaccines Distributors
11.3 Polio Vaccines Customer

12 WORLD FORECAST REVIEW FOR POLIO VACCINES BY GEOGRAPHIC REGION

12.1 Global Polio Vaccines Market Size Forecast by Region
  12.1.1 Global Polio Vaccines Forecast by Region (2024-2029)
  12.1.2 Global Polio Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Polio Vaccines Forecast by Type
12.7 Global Polio Vaccines Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 CSL
  13.1.1 CSL Company Information
  13.1.2 CSL Polio Vaccines Product Portfolios and Specifications
  13.1.3 CSL Polio Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 CSL Main Business Overview
  13.1.5 CSL Latest Developments
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Information
  13.2.2 GlaxoSmithKline Polio Vaccines Product Portfolios and Specifications
  13.2.3 GlaxoSmithKline Polio Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 GlaxoSmithKline Main Business Overview
  13.2.5 GlaxoSmithKline Latest Developments
13.3 Johnson & Johnson
  13.3.1 Johnson & Johnson Company Information
  13.3.2 Johnson & Johnson Polio Vaccines Product Portfolios and Specifications
  13.3.3 Johnson & Johnson Polio Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Johnson & Johnson Main Business Overview
  13.3.5 Johnson & Johnson Latest Developments
13.4 MedImmune
  13.4.1 MedImmune Company Information
  13.4.2 MedImmune Polio Vaccines Product Portfolios and Specifications
  13.4.3 MedImmune Polio Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 MedImmune Main Business Overview
  13.4.5 MedImmune Latest Developments
13.5 Merck
  13.5.1 Merck Company Information
  13.5.2 Merck Polio Vaccines Product Portfolios and Specifications
  13.5.3 Merck Polio Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Merck Main Business Overview
  13.5.5 Merck Latest Developments
13.6 Pfizer
  13.6.1 Pfizer Company Information
  13.6.2 Pfizer Polio Vaccines Product Portfolios and Specifications
  13.6.3 Pfizer Polio Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Pfizer Main Business Overview
  13.6.5 Pfizer Latest Developments
13.7 Sanofi Pasteur
  13.7.1 Sanofi Pasteur Company Information
  13.7.2 Sanofi Pasteur Polio Vaccines Product Portfolios and Specifications
  13.7.3 Sanofi Pasteur Polio Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Sanofi Pasteur Main Business Overview
  13.7.5 Sanofi Pasteur Latest Developments
13.8 Serum Institute
  13.8.1 Serum Institute Company Information
  13.8.2 Serum Institute Polio Vaccines Product Portfolios and Specifications
  13.8.3 Serum Institute Polio Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Serum Institute Main Business Overview
  13.8.5 Serum Institute Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Polio Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Polio Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of IPV
Table 4. Major Players of OPV
Table 5. Global Polio Vaccines Sales by Type (2018-2023) & (K Units)
Table 6. Global Polio Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Polio Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Polio Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Polio Vaccines Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Polio Vaccines Sales by Application (2018-2023) & (K Units)
Table 11. Global Polio Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Polio Vaccines Revenue by Application (2018-2023)
Table 13. Global Polio Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Polio Vaccines Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Polio Vaccines Sales by Company (2018-2023) & (K Units)
Table 16. Global Polio Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Polio Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Polio Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Polio Vaccines Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Polio Vaccines Producing Area Distribution and Sales Area
Table 21. Players Polio Vaccines Products Offered
Table 22. Polio Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Polio Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Polio Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Polio Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Polio Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Polio Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Polio Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Polio Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Polio Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Polio Vaccines Sales by Country (2018-2023) & (K Units)
Table 34. Americas Polio Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Polio Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Polio Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Polio Vaccines Sales by Type (2018-2023) & (K Units)
Table 38. Americas Polio Vaccines Sales by Application (2018-2023) & (K Units)
Table 39. APAC Polio Vaccines Sales by Region (2018-2023) & (K Units)
Table 40. APAC Polio Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Polio Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Polio Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Polio Vaccines Sales by Type (2018-2023) & (K Units)
Table 44. APAC Polio Vaccines Sales by Application (2018-2023) & (K Units)
Table 45. Europe Polio Vaccines Sales by Country (2018-2023) & (K Units)
Table 46. Europe Polio Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Polio Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Polio Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Polio Vaccines Sales by Type (2018-2023) & (K Units)
Table 50. Europe Polio Vaccines Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Polio Vaccines Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Polio Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Polio Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Polio Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Polio Vaccines Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Polio Vaccines Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Polio Vaccines
Table 58. Key Market Challenges & Risks of Polio Vaccines
Table 59. Key Industry Trends of Polio Vaccines
Table 60. Polio Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Polio Vaccines Distributors List
Table 63. Polio Vaccines Customer List
Table 64. Global Polio Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Polio Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Polio Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Polio Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Polio Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Polio Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Polio Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Polio Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Polio Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Polio Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Polio Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Polio Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Polio Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Polio Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. CSL Basic Information, Polio Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. CSL Polio Vaccines Product Portfolios and Specifications
Table 80. CSL Polio Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. CSL Main Business
Table 82. CSL Latest Developments
Table 83. GlaxoSmithKline Basic Information, Polio Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. GlaxoSmithKline Polio Vaccines Product Portfolios and Specifications
Table 85. GlaxoSmithKline Polio Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. GlaxoSmithKline Main Business
Table 87. GlaxoSmithKline Latest Developments
Table 88. Johnson & Johnson Basic Information, Polio Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson & Johnson Polio Vaccines Product Portfolios and Specifications
Table 90. Johnson & Johnson Polio Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Johnson & Johnson Main Business
Table 92. Johnson & Johnson Latest Developments
Table 93. MedImmune Basic Information, Polio Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. MedImmune Polio Vaccines Product Portfolios and Specifications
Table 95. MedImmune Polio Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. MedImmune Main Business
Table 97. MedImmune Latest Developments
Table 98. Merck Basic Information, Polio Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Polio Vaccines Product Portfolios and Specifications
Table 100. Merck Polio Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Pfizer Basic Information, Polio Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Polio Vaccines Product Portfolios and Specifications
Table 105. Pfizer Polio Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Sanofi Pasteur Basic Information, Polio Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Pasteur Polio Vaccines Product Portfolios and Specifications
Table 110. Sanofi Pasteur Polio Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Sanofi Pasteur Main Business
Table 112. Sanofi Pasteur Latest Developments
Table 113. Serum Institute Basic Information, Polio Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Serum Institute Polio Vaccines Product Portfolios and Specifications
Table 115. Serum Institute Polio Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Serum Institute Main Business
Table 117. Serum Institute Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Polio Vaccines
Figure 2. Polio Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Polio Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Polio Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Polio Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of IPV
Figure 10. Product Picture of OPV
Figure 11. Global Polio Vaccines Sales Market Share by Type in 2022
Figure 12. Global Polio Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Polio Vaccines Consumed in Age (0-1)
Figure 14. Global Polio Vaccines Market: Age (0-1) (2018-2023) & (K Units)
Figure 15. Polio Vaccines Consumed in Age Above 1
Figure 16. Global Polio Vaccines Market: Age Above 1 (2018-2023) & (K Units)
Figure 17. Global Polio Vaccines Sales Market Share by Application (2022)
Figure 18. Global Polio Vaccines Revenue Market Share by Application in 2022
Figure 19. Polio Vaccines Sales Market by Company in 2022 (K Units)
Figure 20. Global Polio Vaccines Sales Market Share by Company in 2022
Figure 21. Polio Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Polio Vaccines Revenue Market Share by Company in 2022
Figure 23. Global Polio Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Polio Vaccines Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Polio Vaccines Sales 2018-2023 (K Units)
Figure 26. Americas Polio Vaccines Revenue 2018-2023 ($ Millions)
Figure 27. APAC Polio Vaccines Sales 2018-2023 (K Units)
Figure 28. APAC Polio Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. Europe Polio Vaccines Sales 2018-2023 (K Units)
Figure 30. Europe Polio Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Polio Vaccines Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Polio Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Americas Polio Vaccines Sales Market Share by Country in 2022
Figure 34. Americas Polio Vaccines Revenue Market Share by Country in 2022
Figure 35. Americas Polio Vaccines Sales Market Share by Type (2018-2023)
Figure 36. Americas Polio Vaccines Sales Market Share by Application (2018-2023)
Figure 37. United States Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Polio Vaccines Sales Market Share by Region in 2022
Figure 42. APAC Polio Vaccines Revenue Market Share by Regions in 2022
Figure 43. APAC Polio Vaccines Sales Market Share by Type (2018-2023)
Figure 44. APAC Polio Vaccines Sales Market Share by Application (2018-2023)
Figure 45. China Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Polio Vaccines Sales Market Share by Country in 2022
Figure 53. Europe Polio Vaccines Revenue Market Share by Country in 2022
Figure 54. Europe Polio Vaccines Sales Market Share by Type (2018-2023)
Figure 55. Europe Polio Vaccines Sales Market Share by Application (2018-2023)
Figure 56. Germany Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Polio Vaccines Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Polio Vaccines Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Polio Vaccines Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Polio Vaccines Sales Market Share by Application (2018-2023)
Figure 65. Egypt Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Polio Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Polio Vaccines in 2022
Figure 71. Manufacturing Process Analysis of Polio Vaccines
Figure 72. Industry Chain Structure of Polio Vaccines
Figure 73. Channels of Distribution
Figure 74. Global Polio Vaccines Sales Market Forecast by Region (2024-2029)
Figure 75. Global Polio Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Polio Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Polio Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Polio Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Polio Vaccines Revenue Market Share Forecast by Application (2024-2029)